84 related articles for article (PubMed ID: 27537052)
1. Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization.
Genua M; Ingangi V; Fonteyne P; Piontini A; Yousif AM; Merlino F; Grieco P; Malesci A; Carriero MV; Danese S
Inflamm Bowel Dis; 2016 Oct; 22(10):2390-401. PubMed ID: 27537052
[TBL] [Abstract][Full Text] [Related]
2. Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.
Yousif AM; Minopoli M; Bifulco K; Ingangi V; Di Carluccio G; Merlino F; Motti ML; Grieco P; Carriero MV
PLoS One; 2015; 10(5):e0126172. PubMed ID: 25938482
[TBL] [Abstract][Full Text] [Related]
3. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical grade synthetic peptide Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu ameliorates DSS-induced murine colitis by reducing the number and pro-inflammatory activity of colon tissue-infiltrating Ly6G
Chulkina MM; Pichugin AV; Ataullakhanov RI
Peptides; 2020 Oct; 132():170364. PubMed ID: 32621844
[TBL] [Abstract][Full Text] [Related]
5. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis.
Marcon R; Bento AF; Dutra RC; Bicca MA; Leite DF; Calixto JB
J Immunol; 2013 Oct; 191(8):4288-98. PubMed ID: 24038091
[TBL] [Abstract][Full Text] [Related]
6. Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration.
Yousif AM; Ingangi V; Merlino F; Brancaccio D; Minopoli M; Bellavita R; Novellino E; Carriero MV; Carotenuto A; Grieco P
Eur J Med Chem; 2018 Jan; 143():348-360. PubMed ID: 29202399
[TBL] [Abstract][Full Text] [Related]
7. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
8. The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.
Ingangi V; Bifulco K; Yousif AM; Ragone C; Motti ML; Rea D; Minopoli M; Botti G; Scognamiglio G; Fazioli F; Gallo M; De Chiara A; Arra C; Grieco P; Carriero MV
Oncotarget; 2016 Aug; 7(34):54474-54487. PubMed ID: 27323409
[TBL] [Abstract][Full Text] [Related]
9. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
10. An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor.
Bifulco K; Longanesi-Cattani I; Gargiulo L; Maglio O; Cataldi M; De Rosa M; Stoppelli MP; Pavone V; Carriero MV
FEBS Lett; 2008 Apr; 582(7):1141-6. PubMed ID: 18339322
[TBL] [Abstract][Full Text] [Related]
11. RAMP1 suppresses mucosal injury from dextran sodium sulfate-induced colitis in mice.
Kawashima-Takeda N; Ito Y; Nishizawa N; Kawashima R; Tanaka K; Tsujikawa K; Watanabe M; Majima M
J Gastroenterol Hepatol; 2017 Apr; 32(4):809-818. PubMed ID: 27513455
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells.
Munakata S; Tashiro Y; Nishida C; Sato A; Komiyama H; Shimazu H; Dhahri D; Salama Y; Eiamboonsert S; Takeda K; Yagita H; Tsuda Y; Okada Y; Nakauchi H; Sakamoto K; Heissig B; Hattori K
Gastroenterology; 2015 Mar; 148(3):565-578.e4. PubMed ID: 25490065
[TBL] [Abstract][Full Text] [Related]
13. Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization.
Nakanishi Y; Sato T; Ohteki T
Mucosal Immunol; 2015 Jan; 8(1):152-60. PubMed ID: 24938744
[TBL] [Abstract][Full Text] [Related]
14. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
15. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
[TBL] [Abstract][Full Text] [Related]
16. Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis.
Bai A; Yong M; Ma AG; Ma Y; Weiss CR; Guan Q; Bernstein CN; Peng Z
J Pharmacol Exp Ther; 2010 Jun; 333(3):717-25. PubMed ID: 20237071
[TBL] [Abstract][Full Text] [Related]
17. Human neutrophil peptide-1 aggravates dextran sulfate sodium-induced colitis.
Hashimoto S; Uto H; Kanmura S; Sakiyama T; Oku M; Iwashita Y; Ibusuki R; Sasaki F; Ibusuki K; Takami Y; Moriuchi A; Oketani M; Ido A; Tsubouchi H
Inflamm Bowel Dis; 2012 Apr; 18(4):667-75. PubMed ID: 21928371
[TBL] [Abstract][Full Text] [Related]
18. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.
Carriero MV; Longanesi-Cattani I; Bifulco K; Maglio O; Lista L; Barbieri A; Votta G; Masucci MT; Arra C; Franco R; De Rosa M; Stoppelli MP; Pavone V
Mol Cancer Ther; 2009 Sep; 8(9):2708-17. PubMed ID: 19706734
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.
Minopoli M; Polo A; Ragone C; Ingangi V; Ciliberto G; Pessi A; Sarno S; Budillon A; Costantini S; Carriero MV
Sci Rep; 2019 Aug; 9(1):12169. PubMed ID: 31434916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
